NCT02264821View on ClinicalTrials.gov

Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia

PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Post Caesarean Analgesia
Interventions
DRUG

ropivacaine infiltration

wound infiltration

DRUG

intrathecal morphine

100 µg added to the spinal anaesthesia

DRUG

placebo

placebo in spinal anaesthesia and in wound infiltration

Trial Locations (1)

1020

Centre Hospitalier Universitaire Brugmann, Brussels

All Listed Sponsors
lead

Dr Madeleine Wilwerth

OTHER

NCT02264821 - Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia | Biotech Hunter | Biotech Hunter